Cellectar Biosciences stock forecast
Cellectar Biosciences (NV40) Stock Forecast & Price Target
NV40 Analyst Ratings
NV40 Stock 12 Month Forecast
Average Price Target
€8.95▲(3008.85% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | €8.95 | buy | 3008.85%Upside | Reiterated | 11/10/26 | ||
| Kevin DeGeeter | Ladenburg Thalmann & Co. | €8.95 | buy | 3008.85%Upside | Reiterated | 08/14/26 | ||
| Kemp Dolliver | Brookline Capital Markets | €13.43 | buy | 4563.28%Upside | Initiated | 07/12/26 | ||
| Jonathan Aschoff | Roth MKM | €12.53→€9.85 | buy | 3319.74%Upside | Assigned | 05/05/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jason McCarthyMaxim Group | BuyReiterated€8.95 | 11/10/26 | 3008.85%Upside | ||
| Kevin DeGeeterLadenburg Thalmann & Co. | BuyReiterated€8.95 | 08/14/26 | 3008.85%Upside | ||
| Kemp DolliverBrookline Capital Markets | BuyInitiated€13.43 | 07/12/26 | 4563.28%Upside | ||
| Jonathan AschoffRoth MKM | BuyAssigned€12.53→€9.85 | 05/05/26 | 3319.74%Upside |
Best Analysts Covering Cellectar Biosciences
Copying Kevin DeGeeter's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -1.20% per trade.
Copying Kevin DeGeeter's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.51% per trade.
Copying Kevin DeGeeter's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -75.87% per trade.
NV40 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 3 | 3 | 2 | 1 |
In the current month, NV40 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NV40 average Analyst price target in the past 3 months is 8.95.
NV40 Financial Forecast
NV40 Earnings Forecast
Next quarter’s earnings estimate for NV40 is -EUR 0.46 with a range of -EUR 0.53 to -EUR 0.39. The previous quarter’s EPS was -EUR 0.41. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NV40 Sales Forecast
Next quarter’s sales forecast for NV40 is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
